The TiNT Trial: A phase II clinical trial of trametinib in paediatric patients with neurofibromatosis type 1 associated progressive optic pathway gliomas

  • McCowage, Geoffrey B. (Primary Chief Investigator (PCI))
  • Dodgshun, Andrew J. (Chief Investigator (CI))
  • Payne, Jonathan M. (Chief Investigator (CI))
  • Barton , Belinda A (Chief Investigator (CI))
  • Dabscheck, Gabriel (Chief Investigator (CI))
  • Kinross, Kathryn (Chief Investigator (CI))
  • Strong, Robyn (Project Manager)
  • Jones, Janelle (Project Manager)
  • May, Kylie (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date1/06/20 → 31/05/27

Keywords

  • glioma
  • targeted therapy
  • neurocognitive assessment
  • paediatric
  • clinical trial